Skip to main content

Table 1 Sociodemographic data and acne severity at baseline visit

From: Adherence to drug treatments and adjuvant barrier repair therapies are key factors for clinical improvement in mild to moderate acne: the ACTUO observational prospective multicenter cohort trial in 643 patients

  n mean (SD) n (%)
Gender Male 635 -- 240 (37.8 %)
Female 395 (62.2 %)
Age 617 21.3 (7.2)  
Study level Primary school 632 -- 24 (3.8 %)
Secondary school 151 (23.9 %)
Vocational training (school) 51 (8.1 %)
Pre-university 188 (29.7 %)
Vocational training (technical college) 30 (4.7 %)
First cycle university studies 41 (6.5 %)
Second cycle university studies 146 (23.1 %)
Others 1 (0.2 %)
Physician’s acne evaluation Without lesions 640 2.47 (0.64) --
Practically without lesions 32 (5.0 %)
Mild 298 (46.6 %)
Moderate 290 (45.3 %)
Severe 20 (3.1 %)
Patient’s acne evaluation Without lesions 594 2.10 (0.85) 16 (2.7 %)
Practically without lesions 126 (21.2 %)
Mild 245 (41.2 %)
Moderate 195 (32.8 %)
Severe 12 (2.0 %)
Lesion locationa Facial 637 -- 622 (97.6 %)
Back 212 (33.3 %)
Shoulders 81 (12.7 %)
Presternal area 73 (11.5 %)
Others 2 (0.3 %)
Total number of lesionsa(Percentages of 568 patients with lesions) Comedones 546 18.9 (20.4) 532 (93.7 %)
Papules/pustules 551 11.4 (10.2) 545 (96.0 %)
Nodules 378 0.9 (1.7) 147 (25.9 %)
Recommendation of specific adjuvant products (facial soaps/cleansers and specific facial care products) No 640 -- 104 (16.3 %)
Yes 536 (83.8 %)
  1. aNon-exclusive categories
  2. N number of patients, SD standard deviation; % = Percentage